Daniel S Lefler

7PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 16, 2026
Liposomal Versus Conventional Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas: Observational Multi-Institutional Cohort of 8.5-Year Experience.

|Jul 02, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.

Daniel S Lefler, Andrew Elliott, Wei Jiang

|Feb 23, 2024
Immunotherapy resistance in solid tumors: mechanisms and potential solutions.

Daniel S Lefler, Steven A Manobianco, Babar Bashir

|Nov 22, 2023
Liver Transplantation in a Woman with Mahvash Disease.

Justin Robbins, Dina Halegoua-DeMarzio, Atrayee Basu Mallick

|Mar 02, 2023
Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications.

Grant W Jirka, Daniel S Lefler, Jessica Russo

|Jun 13, 2022
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1.

Daniel S Lefler, Adam E Snook, Babar Bashir

Pageof 2

Frequent Collaborators

4 joint publications

Babar Bashir

1 joint publications

Adam E Snook

1 joint publications

Grant W Jirka

1 joint publications

Jessica Russo